HER Foundation

@HGmoms

HER Foundation is the voice of HG, a pregnancy condition that increases risk of maternal & fetal mortality and morbidity.

Дата приєднання: березень 2012

твіти

Ви заблокували @HGmoms

Ви впевнені, що хочете переглянути ці твіти? Перегляд твітів не розблокує профіль @HGmoms

  1. Закріплений твіт
    13 лют.

    Imagine consistent standards of care to reduce suffering and preventable complications of HG. Be part of HG Progress! Support another 20 years of helping mothers & babies thrive: .

    Скасувати
  2. 2 години тому
    Скасувати
  3. 2 години тому

    In 2007, 15% of women reported therapeutic terminations of wanted pregnancies due to HG primarily because of no hope for relief & more often reported uncaring providers. The rate is now 6% due in part to the education & support provided by HER. .

    Скасувати
  4. 3 години тому

    Thiamin (100 mg/day) must become standard of care for women with Hyperemesis Gravidarum! Daily thiamin prevents serious complications including Wernicke's encephalopathy. WE Fact Sheet: .

    Скасувати
  5. 6 годин тому

    Support women at risk for PMADs! Earn 16 ceus over two days training with Elizabeth Lowder MSW, LCSW and Kim Martino-Sexton NFC will train participants on their “Heartland Protocol” for PMADs. May 5-6: .

    Скасувати
  6. 27 квіт.

    Do you have patients with refactory HG? Consider granisetron. Samples are available here: . (HER is not affiliated with Sancuso.)

    Скасувати
  7. 27 квіт.
    Скасувати
  8. 27 квіт.

    May 15th is HG Awareness Day! The international HG community is shining light on HG Truths all month! Don't miss any events, education, and advocacy: .

    Скасувати
  9. 27 квіт.

    Our own Danielle Plummer, PharmD and member of HER's Board can be heard talking about her HG experience on Dose of Support podcast. Don't miss it: .

    Скасувати
  10. 26 квіт.

    The HyperEmesis Level Prediction Score developed by the HER Foundation quantifies HG symptoms into a score that can be trended over time to monitor progress and response to treatment: .

    , , і ще 7
    Скасувати
  11. 26 квіт.

    In March hosted a webinar: Impact of COVID-19 and Women’s Health Challenges & Lessons. HER joined AHN, , & other experts to discuss the impact of COVID-19 on women’s access to healthcare services: .

    Скасувати
  12. 26 квіт.

    Our March Volunteer in Action is ! She is HER's Medical Advisor, a member of the Board of Directors. Thank you for all you do, Aimee!

    Скасувати
  13. 25 квіт.

    We're advancing current guidelines by developing a comprehensive treatment algorithm to help clinicians in managing HG. It takes ACOG guidelines and recommended treatment options and puts them into a practical format. Download: .

    Скасувати
  14. ретвітнув(ла)
    24 квіт.
    Скасувати
  15. ретвітнув(ла)
    25 квіт.

    When you minimise confounding by indication + do a proper time of exposure analysis, ondansetron in pregnancy doesn’t increase risk of fetal death or malformation

    Скасувати
  16. 25 квіт.

    Join us Live at 5 PM/Pacific on Instagram, 4/25: . Kimber MacGibbon, RN, and Danielle Plummer, PharmD, will talk about advocating for better care.

    Скасувати
  17. 25 квіт.

    There are many strategies to optimize HG treatment. HER Foundation has developed evidence-based tools to support you in caring for your patients: .

    Скасувати
  18. 25 квіт.
    Скасувати
  19. 24 квіт.

    Have you read our study demonstrating the effectiveness of the HyperEmesis Level Prediction (HELP) Score in identifying pregnant women with severe symptoms of nausea and vomiting in pregnancy (NVP)? Study: .

    Скасувати
  20. 23 квіт.
    Скасувати
  21. 23 квіт.

    HG has an 80% recurrence rate, so it is best for HG patients to be prepared for a subsequent pregnancy: .

    Скасувати

Схоже, завантаження займе трохи часу.

Можливо, Твіттер перенавантажено або виникли тимчасові труднощі. Спробуйте ще раз або дізнайтеся більше про стан Твіттера.

    Вам також може сподобатись

    ·